| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,058,300 | 1,042,550 | 1,052,764 | 1,052,862 | | Cost of Revenue | (205,455) | 350,861 | 385,704 | 415,507 | | | Gross Profit | 1,263,755 | 691,689 | 667,060 | 637,355 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,055,106 | 410,070 | 412,448 | 429,506 | | Non Recurring | (4,277) | 2,086 | 2,191 | 393,255 | | Others | 147,586 | 138,614 | 137,651 | 143,709 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 57,692 | 140,919 | 114,770 | (329,115) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (5,323) | 749 | 757 | 1,419 | | Earnings Before Interest And Taxes | 83,143 | 166,462 | 140,854 | (302,076) | | Interest Expense | 19,358 | 19,387 | 19,022 | 16,579 | | Income Before Tax | 63,785 | 147,075 | 121,832 | (318,655) | | Income Tax Expense | 22,541 | 57,748 | 31,232 | (129,007) | | Minority Interest | (17,583) |
-
|
-
| (10,470) | | | | Net Income From Continuing Ops | 96,908 | 89,327 | 90,600 | (200,118) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 23,661 | 89,327 | 90,600 | (200,118) | | Preferred Stock And Other Adjustments | 11,977 | (5,969) | (6,008) |
-
| | | Net Income Applicable To Common Shares | $35,638 | $83,358 | $84,592 | ($200,118) |
|
0.11% Nasdaq 
0.01%
Income Statement
